Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - GENVEC INCFinancial_Report.xls
EX-32.2 - EXHIBIT 32.2 - GENVEC INCv343876_ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - GENVEC INCv343876_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - GENVEC INCv343876_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - GENVEC INCv343876_ex31-1.htm
EX-10.1 - EXHIBIT 10.1 - GENVEC INCv343876_ex10-1.htm
10-Q - 10-Q - GENVEC INCv343876_10q.htm

 

EXHIBIT 10.2

 

AMENDMENTOF SOLICITATIONIMODIFICATICATION OF CONTRACT

1.  CONTRACT ID CODE
 
PAGE     OF      PAGES
1      |       5

2. AMENDMENT/MODIFICATION NO.

  P00005

3. EFFECTIVE DATE

See Block 16C

4. REQUISITION/PURCHASE REQ. NO.

RSAG—13—00027

5. PROJECT NO. (If applicable)

FAD

6. ISSUED BY                      CODE

U.S.   Dept. of Homeland Security
Office of Procurement Operations
S&T Acquisition Division
245 Murray Lane, SW
Building 410
Washington DC 20528
DHS/OPO/S&T/CHEMB 7. ADMINISTERED BY (if other than Item 6)

U.S.   Dept. of Homeland Security
Office of Procurement Operations
S&T Acquisition Division
245 Murray Lane, SW
Building 410 Washington DC 20528
CODE DHS/OPO/S&T/CHEM1
   
   
   
   
   
   

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, Slate and Zip Code)

 

 

GENVEC INC

65 WEST WATKINS MILL ROAD ATTN JO AFUANG

GAITHERSBURG MD 208784021

(x} 9A. AMENDMENT OF SOLICITATION NO.
9B DATED (SEE ITEM 11)

 

x

10A, MODIFICATION OF CONTRACT/ORDER NO.
     HSHQDC—10—C —00034

10B. DATED (SEE ITEM 13)

01/22/2010

 

CODE          8067295470000             FACILITY CODE:    

11, THIS ITEM ONLY APPLIES TO AMENDMENTS Of SOLICITATIONS

¨ The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers            ¨ is extended,       ¨ is not extended. Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items 8 and 15, and returning _____________ copies of the Amendment, (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or latter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

 

12. ACCOUNTING AND APPROPRIATION DATA (if required)                        Net Increase:

3100000-000-35-55-01-06-000-08-02-0000-00-00-00-00-GE-OE-25-50-000000

$409,934.00

13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

CHECK ONE A.   THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10a
 
  B.   THE ABOVE NUM BERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
x C.   THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
FAR 52.243-2 Changes- Cost Reimbursement Alternate I (April 1984)
  D.   OTHER (Specify type of modification and authority)
   

 

E. IMPORTANT:           Contractor       ¨ is not      xis required to sign this document and return ______________    copies to the Issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitator/contract subject matter where feasible)

DUNS Number: 806729547+0000

(See page 3 for modification details.)

AAP Number: NONE DO/DPAS Rating: NONE

Discount Terms:

Net 30

FOB: Destination

Period of Performance: 01/22/2010 to 12/31/2013

 

Add Item 0004 as follows:

 

0004   Foot-and-Mouth Disease Vaccine Research and

409,934.00

Continued ...  

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print).


Douglas J. Swirsky

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)


Shelby Buford, Jr.

15B. CONTRACTOR/OFFEROR 15C.. DATE SIGNED 16B. UNITED STATES OF AMERICA 16C. DATE SIGNED
/s/ Douglas J. Swirsky 3/21/13 

/s/ Shelby Buford

3/19/2013
(Signature of person Authorized to sign)   (Signature of Contracting Officer)  

 

** The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission

 

1 of 5
 

 

CONTINUATION SHEET

REFERENCE NO. OFAMENDMENT BEING CONTINUED

  PAGE OF OF

  HSHQDC-10-C-00034/P00005   2             5

 

NAM E OF OFFEROR OR CONTRACTOR

GENVEC INC

ITEM NO.
(A)

SUPPLY SERVICES

(B)

QUANTITY
(C)
UNIT
(D)
UNIT PRICE
(E)

AMOUNT
(F)

 

Manufacturing Development Obligated Amount: 409,934.00

       

 

** The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission

 

2 of 5
 

 

P00005

HSHQDC-10-C-00034

 

The purpose of P00005 for HSHQDC-10-C-00034 is to reallocate funds and modify at no additional cost to DHS S&T the research milestones, add a new Research Milestone (RM6) with associated deliverables, modify the development milestones, update the resource manager point of contact and extend the current period of performance.

 

1) Add CLIN 00004 with funding in the amount of $409,934.00

 

RM5: **

RM6: **

 

2) The total amount for the contract is increased from $4,955,888.00 by $409,934.00 to $5,365,822.00

 

3) The Research Milestones are modified as follows:

 

Research Milestone RM1 (no-cost modification) — **

·   **

 

Research Milestone RM3 (no-cost modification) — **

·   **

Research Milestone RM4 (no-cost modification) — **

·   **

 

Research Milestone RM5 (cost-modification) — **

·   **

 

Research Milestone RM6 (new milestone; cost modification) — **

·   **

 

4) The Development Milestones (no cost modifications) are modified as follows:

 

Development Milestone DM1— **

1.    **

 

** The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission

 

3 of 5
 

 

P00005

HSHQDC-10-C-00034

 

Development Milestone DM2 — **

Development Milestone DM3 — **

 

3) The Deliverables are modified as follows:

 

    Milestone   Deliverables   Timeline for Completion  
               
RM1  

**

 

 

**

 

 

**

 

 
               
RM4  

**

 

 

**

 

 

**

 

 
               
RM5  

**

 

 

**

 

 

**

 

 
               
RM6*  

**

 

 

**

 

 

**

 

 

 

** The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission

 

4 of 5
 

 

 

    Milestone   Deliverables   Timeline for Completion  
               
DM1    

**

 

 

**

 

 

**

 

 
               
DM2    

**

 

 

**

 

 

**

 

 
               
DM3    

**

 

 

**

 

 

**

 

 

 

5)  The Period of Performance is extended

 

From: 01/22/2010 through 06/30/2013
To: 01/22/2010 through 12/31/2013

 

6)   ** has replaced ** as the Resource Manager.

 

**

Department of Homeland Security

Science and Technology Directorate

Voice: **

Email: **

 

7)  All other terms and conditions remain unchanged and in full force and effect.

 

END OF MODIFICATION

 

** The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission

 

5 of 5